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Versican, a Major Hyaluronan-Binding Component
in the Dermis, Loses its Hyaluronan-Binding Ability
in Solar Elastosis
Keiko Hasegawa1, Masahiko Yoneda1, Hiroko Kuwabara2, Osamu Miyaishi3, Naoki Itano4, Akiko Ohno5,
Masahiro Zako5 and Zenzo Isogai6
Versican interacts with hyaluronan (HA) at its N-terminus and with fibrillin-1 at its C terminus. As versican in the
dermis connects microfibrils to the HA-rich matrix for viscoelasticity, dermal diseases may involve destruction
of these complexes. A recombinant versican protein, rVN, covering the HA binding region (HABR) of human
versican and a polyclonal antibody, 6084, against rVN were prepared and characterized. Blotting analyses of skin
extracts with 6084 and biotin-conjugated HA revealed that versican was a major HA-binding component in the
dermis. Matrix metalloprotease-12, which is expressed in areas of solar elastosis, degraded versican and
abrogated its HA-binding ability. Immunohistochemical analyses revealed that the elastic materials in solar
elastosis lesions were negative for 6084, but positive for 2B1, an antibody recognizing the C-terminus of
versican, indicating loss of the HABR in the aggregated elastic fibers. This loss of the HA-binding ability of
versican followed by HA exclusion may be responsible for the pathological and phenotypical changes observed
in solar elastosis.
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INTRODUCTION
Dermal connective tissue comprises three distinct elements;
elastic fibers, collagen fibers, and ground substance. These
three elements interact and connect with each other and also
play roles in the dermal architecture. Elastic fibers are
composed of two distinct elements, elastin and microfibrils.
Microfibrils are elastic cross-linked polymers mainly com-
posed of fibrillins and are present throughout elastic fiber
elements including elaunin and oxytalan (Sakai et al., 1986).
Collagen fibers play important roles in maintaining the
structural integrity of the dermis. Ground substance is mainly
composed of hyaluronan (HA) and proteoglycans, and
contributes to the formation of water-rich matrices. HA,
which lacks a core protein, holds huge amounts of water non-
covalently and is integrated within the dermal connective
tissue through its binding of molecules.
Versican, also called PG-M, is a lectican family proteo-
glycan that is present in the fetal, neonatal, and adult dermis
in humans (Zimmermann et al., 1994; Sorrell et al., 1999).
We previously reported that versican interacts with both
fibrillin-1 and isolated microfibrils (Isogai et al., 2002).
Versican binds fibulin-1 and -2 via its lectin-like domain
and localizes to cutaneous microfibrils (Zimmermann et al.,
1994; Aspberg et al., 1999; Olin et al., 2001; Isogai et al.,
2002). Versican also binds to HA via its N-terminal region
(LeBaron et al., 1992) and HA is co-distributed with elastic
fibers in the dermis (Bernstein et al., 1996). Therefore, by
binding to fibrillin microfibrils and HA, versican can impart
viscous properties to cutaneous microfibrils.
Photoaged dermis displays characteristic pathological
features, designated as solar elastosis. Both the synthesis
and degradation of matrix components have been investi-
gated for the development of solar elastosis (Sellheyer, 2003).
In solar elastosis lesions, accumulations of elastin and
microfibril components, including fibrillin-1 (Da¨hlback
et al., 1990), LTBP-1 (Karonen et al., 1997), versican
(Bernstein et al., 1995), fibulin-2 (Hunzelmann et al.,
2001), and fibulin-5 (Kadoya et al., 2005) have been
reported. However, the structural and functional properties
of these accumulated molecules in solar elastosis lesions
remain to be elucidated.
Matrix metalloprotease-12 (MMP-12), also known as
macrophage metalloelastase, degrades elastin (Shapiro
et al., 1993) and plays critical roles in the development of
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emphysema and aortic aneurysms that are caused by elastic
fiber degeneration (Hautamaki et al., 1997; Curci et al.,
1998). Immunohistochemical studies have revealed that
MMP-12 is localized in solar elastosis lesions (Saarialho-Kere
et al., 1999) and granulomatous skin disease (Vaalamo et al.,
1999). Moreover, ultraviolet irradiation and heat treatment
induce MMP-12 at the mRNA level in vivo (Chung et al.,
2002; Chen et al., 2005). Therefore, MMP-12 is likely to play
critical roles in the development of solar elastosis, possibly by
modifying the structure and functions of the extracellular
matrix (ECM) in the dermis. Thus, the impact of MMP-12 on
the structural and functional properties of elastic fibers
represent an important issue for a better understanding of
the phenotypical and pathological changes of photoaged
skin.
In this study, we investigate HA-binding molecules in
adult skin and identify versican as a major HA-binding
molecule. We also find that the N-terminal fragments of
versican are cleaved in adult skin, but are still capable of
binding to HA. Moreover, we find MMP-12 abolishes the HA-
binding ability of versican in vitro, indicating that versican
which localizes in solar elastosis lesions, is likely to lose its
HA-binding activity.
RESULTS
Recombinant expression and characterization of the HABR of
versican
To characterize the HA-binding activity of versican, the HA-
binding region (HABR) of versican was recombinantly
expressed (Figure 1). An expression construct that spanned
the N-terminal half of versican (V3) was created and
transfected into 293 human kidney cells. The recombinant
polypeptide, designated rVN, was secreted into the medium
with a good yield. The purified proteins displayed a doublet
of bands on SDS–PAGE (Figure 2, lane 3). Both bands reacted
with an anti-hexahistidine antibody and their N-terminal
sequences were the same. The binding affinity for HA in the
soluble phase was further shown by isopycnic ultracentrifu-
gation (Figure 2b).
Production and characterization of a polyclonal antibody
against the HABR of versican
To characterize the HABR of versican, a polyclonal antibody
was raised against gel-purified rVN. Western blot analysis of
crude conditioned media from normal skin fibroblasts
revealed that the antiserum, 6084, specifically recognized
the versican core protein (Figure 3). Furthermore, 2B1, a
monoclonal antibody specific for human versican (Isogai
et al., 1996), showed identical reactivity (Figure 3).
Versican is a major HA-binding component in dermal matrices
and its HABR is cleaved in adult skin
To investigate the major components binding to HA in the
dermis, adult skin was extensively extracted with 6 M
guanidine hydrochloride. The extract was then precipitated,
resolved by SDS–PAGE, and blotted onto membranes.
Incubations with biotin-conjugated HA and 6084 revealed
similar and multiple band patterns, mainly distributed at
Versican (V1)
6084 2B1
Chondroitin sulfate
attachment domain
rVN
Calcium binding EGF-like domain
Lectin-like domain
Hyaluronan binding domain
CRP-like domain
6 histidine
Figure 1. Schematic representation of human versican (V1) and the
recombinant protein used in this study. A recombinant versican fragment
covering the HABR was designed and designated rVN. The nomenclature of
each domain and the antibody recognition sites are indicated.
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Figure 2. Expression and characterization of the HABR of human versican.
(a) Conditioned media from 293 cells expressing rVN (lane 2) and the purified
rVN polypeptide (lane 3) were resolved by 10% SDS–PAGE under non-
reducing conditions. The molecular weights of standard marker proteins are
indicated (lane 1). The gel was stained with Coomassie Brilliant Blue R-250.
(b) Binding assay following cesium chloride density gradient
ultracentrifugation. Conditioned medium from transfected cells expressing
rVN was incubated with HA and then ultracentrifuged in 0.4 M guanidine
hydrochloride containing CsCl. Following the centrifugation, the sample was
divided into three fractions. The densities of the bottom and top fractions were
1.44 g/ml and 1.28 g/ml, respectively. Most of the proteins were fractionated
at the top. The bottom and top fractions were examined by immunoblotting
with an anti-hexahistidine antibody. The rVN detected by the
anti-hexahistidine antibody in the bottom fraction shows non-covalent
binding to HA in solution. HAase, hyaluronidase.
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B60 kDa (Figure 4a), indicating the presence of multiple
proteolytic sites in the versican core protein. Although most
of the bands remained unaffected by chondroitinase ABC
digestion, a band atB500 kDa was generated by the enzyme
treatment (Figure 4a). Immunoblotting with 2B1 revealed that
the B500 kDa band in the chondroitinase ABC-treated
sample corresponded to the versican monomer (Figure 4a).
Immunoblot analyses of the sieved fractions with 6084
demonstrated the presence of the N-terminus of versican
that can bind to HA. These results also suggested that the
major HA-binding molecules in dermal extracts were
N-terminal fragments of versican, probably degraded versi-
can (V1). Since 2B1 does not recognize the HABR of
versican. Immunoblot analyses using monoclonal antibodies
against stubs obtained following chondroitinase ABC diges-
tion also confirmed that versican was the major large
chondroitin sulfate proteoglycan secreted by dermal fibro-
blasts (data not shown).
Hyaluronidase treatment generated 6084-positive bands at
B50 kDa (Figure 5, arrowhead). However, the yield of 6084-
positive bands was approximately one-twentieth the level in
the guanidine extract estimated by immunoblotting. Consis-
tent with this result, considerable amounts of versican
fragments were detected following re-extraction of hyalur-
onidase-treated skin with 6 M guanidine hydrochloride (data
not shown).
MMP-12 abrogates the HA-binding activity of versican
A blot overlay analysis using biotin-conjugated HA revealed
that rVN was capable of binding to HA in solid-phase assays
(Figure 6). MMP-12 digested rVN into undetectable small
fragments and the HA-binding activity of rVN was completely
abrogated as evaluated by HA transblot assays. Reactivity to
polyclonal antibody 6084 was also abolished by MMP-12
treatment (Figure 6). Therefore, 6084 was characterized as
recognizing a conformational epitope of HABR and its
reactivity correlated well with the HA-binding affinity, which
was consistent with the results of the extraction studies
(Figure 4b). By contrast, MMP-12 cleaved a fibrillin-1
peptide, rF23, but the residual fragments were relatively
large (data not shown).
MMP-12 treatment reduces the viscosity of versican-bound
microfibrils
To test whether MMP-12 affects the functional properties of
versican-bound microfibrils, the viscosity of isolated micro-
fibrils from fetal membranes was measured using a Cannon-
Fenske viscometer at 251C. The statistical difference was
determined by two-sided paired-t-test with Po0.0001. That
MMP-12 treatment reduced the viscoelasticity of the isolated
microfibrils is seen in Table 1.
Versican in solar elastosis is unable to bind to HA
Immunohistochemistry revealed that the staining patterns of
2B1 and 6084 were similar in normal skin, suggesting that the
cleaved N-terminus of versican was still associated with
microfibrils in the dermis (Figure 7a–c). In solar elastosis, the
staining with 2B1 was heavily positive, whereas that with
6084 was weak or absent (Figure 7d–f). Staining with 2B1 and
Top
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Figure 3. Specificity of polyclonal antibody 6084. Crude conditioned
medium from normal skin fibroblasts was incubated with or without
chondroitinase ABC (Chase). The samples were resolved by 7.5% SDS–PAGE,
blotted onto membranes, and incubated with 2B1 (a mAb against the C-
terminus of versican) or 6084 (a polyclonal antibody against the N terminus of
versican). The bands in the sample treated with chondroitinase ABC are the
versican monomer (arrowheads).
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Figure 4. The HABR of versican is a major HA-binding component in skin.
(a) Normal skin was extracted with 6 M guanidine hydrochloride and resolved
by SDS–PAGE. (b) To compare between the immunoreactivity of 6084 and the
HA-binding affinity, the extract was fractionated using a Sepharose CL-2B
molecular sieve column. The total volume is at fraction 68 and the void
volume is at fraction 23. The representative fractions indicated in the Figure
were resolved by SDS–PAGE. The blots in a were incubated with 6084, 2B1,
and biotin-HA as described in Materials and Methods. The blots in b were
incubated with 6084 and biotin-HA as indicated. The reactivity of 6084 is
well correlated with the HA-binding activity in b.
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biotin-conjugated HABR in normal skin revealed that
versican and HA were colocalized in microfibrils (Figure
7g–i). By contrast, in areas of solar elastosis, HA was rather
absent from solar elastosis lesions (Figure 7j–l). To exclude
the possibility that the enhanced hyaluronidase activity in
solar elastosis leads to the exclusion of HA in the lesions,
normal and photoaged skin were incubated with HA and
fractionated on a sieve column. However, we did not detect
hyaluronidase activity in either normal skin or solar elastosis
(Figure 8).
DISCUSSION
Skin texture is largely dependent on the architecture created
by its ECM components. For instance, sclerosis, fibrosis, and
wrinkle formation show their own characteristic changes in
ECM components in the dermis. The pathological features of
(kDa)
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Figure 5. Hyaluronidase treatment releases small amounts of versican
fragments. Normal skin pieces were incubated with Streptomyces
hyaluronidase (þ ) or buffer alone () as described in Materials and Methods.
The supernatants were resolved by SDS–PAGE and blotted with polyclonal
antibody 6084. 6084-positive bands ofB42 kDa are generated following the
enzymatic treatment.
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Figure 6. MMP-12 digests rVN and abolishes its reactivity to polyclonal
antibody 6084. Purified rVN was incubated with human MMP-12 (þ ) or
buffer alone (). Aliquots of the samples were resolved by 10% SDS–PAGE,
blotted onto membranes, and incubated with 6084 or biotin-conjugated HA.
The reactivities toward polyclonal antibody 6084 and biotin-conjugated HA
are abolished by MMP-12 treatment.
Table 1. Kinematic viscosity of versican-bound
microfibrils
Non-treated
microfibrils1 (n=40)
MMP-12-treated
microfibrils1 (n=40)
Kinematic viscosity2 1.26370.026 mm2/s 1.17770.021 mm2/s
1Isolated microfibrils were treated with MMP-12 or buffer alone.
2Mean7SD.
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Figure 7. Versican in solar elastosis lesions is unable to bind HA. (a–f; g–l)
Double-immunofluorescence staining of two skin regions with 2B1 (red) and
6084 (green) recognizing the C and N termini of versican, respectively, was
performed on (a–c; g–i) normal skin and (outlined: d–f; j–l) solar elastosis
lesions. Yellow areas in the merged images show coexistence of both termini
of versican (c, f, i, and l). Colocalization of the immunoreactivities for 6084
and HABR is found in normal skin (c and i), whereas very little
immunoreactivity for 6084 is present in the solar elastosis lesions (f and l).
Bar¼100 mm.
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photoaging are characterized as degradation of dermal
collagen and accumulation of elastotic material and proteo-
glycans (Fisher et al., 2002; Sellheyer, 2003). In this study, we
focused on the large chondroitin sulfate proteoglycan
versican, which links elastic fibers to the ground substance.
We have shown, for the first time, that versican is a major
HA-binding component and that its HABR is cleaved in adult
skin.
Using a mammalian cell expression system, we showed
that the G1 domain of versican is sufficient for binding to HA,
as previously predicted (LeBaron et al., 1992). The HABR of
versican was also able to bind to HA in the soluble phase. A
polyclonal antibody, 6084, specifically recognized versican
secreted from fibroblasts in both immunoblotting and
immunohistochemical analyses, indicating that the recombi-
nant protein, rVN, was properly folded and functional. The
observation of a doublet band for rVN may be due to sugar
modifications.
The immunoblotting pattern of guanidine hydrochloride
extract of skin revealed that the N-terminus of versican is
cleaved at multiple sites in adult skin, whereas the versican
monomer was detected with 2B1 and 6084 in fibroblast-
conditioned medium. The good yield of 6084-positive bands
around 60 kDa compared with the yield of 2B1-positive
bands suggests a covalent interaction between the C-terminal
region of versican and cutaneous microfibrils (Isogai et al.,
2002). The cleaved fragments of versican were still capable of
binding to HA. The sizes of the versican N-terminal fragments
detected by 6084 were larger than rVN, and the extracted
fragments were still capable of binding to HA and colocaliz-
ing with HA in the normal dermis. Similar fragments of
versican have been identified in other studies on fetal skin
(Sorrell et al., 1999) and brain (Westling et al., 2004). In
addition, ADAMTS 1 and 4 were reported to cleave versican
in the brain (Westling et al., 2004) and the proteolytic
epitopes of versican generated by ADAMTS 1 and 4 are
present in adult arteries (Sandy et al., 2001). This processing
of versican and other proteoglycans may be required for
maturation of the skin.
Hyaluronidase treatment of skin generated only small
amounts of the N-terminal fragment of versican, suggesting
that the cleaved N terminus is not simply trapped by HA. It
remains unknown how the cleaved N-terminal region of
versican interacts with the other ECM components present in
the skin.
Accumulation of versican in solar elastosis has been
reported (Bernstein et al., 1995; Saarialho-Kere et al., 1999).
Accumulation of HA is also observed in dermal connective
tissue in the normal dermis and at early stages of solar
elastosis (Bernstein et al., 1996). MMP-12 is induced by
ultraviolet irradiation in vivo (Chung et al., 2002) and is
localized to solar elastosis lesions (Saarialho-Kere et al.,
1999). Degradation of versican by MMP-12 may affect the
architectural role of the ECM in photoaged dermis.
On the basis of our biochemical analyses using recombi-
nant rVN or extracted materials from adult skin, reactivity to
6084 is consistently correlated with the HA-binding activity.
Therefore, staining with 6084 could represent HA-binding
activity in situ. Interestingly, staining with 6084 is absent from
areas of massive solar elastosis, whereas 2B1 is positive in
such areas, consistent with previous studies (Bernstein et al.,
1996; Vaalamo et al., 1999). These observations indicate that
the versican accumulated in areas of massive solar elastosis is
unable to bind HA. Consistent with the findings, staining of
HA is faint in regions of massive solar elastosis. Degradation
of versican by MMP-12 could represent a possible mechan-
ism of the aging process of the ECM, As versican and MMP-
12 are accumulated during the development of arteriosclero-
sis and versican degradation is sometimes observed (Halpert
et al., 1996). Furthermore, the reduced viscosity of isolated
versican-bound microfibrils following MMP-12 treatment
may explain these structural–functional correlations.
Although other MMPs are possibly involved, the accumula-
tion of MMP-12 and versican may play distinct functional
roles in pathological changes through disruption of the
viscoelasticity of connective tissues.
MATERIALS AND METHODS
Recombinant expression of the HABR of versican
The HABR of recombinant human versican (rVN) was expressed in
mammalian cells as described previously (Reinhardt et al., 1996). To
create an expression construct for rVN, the region encoding L21 to
R348 of versican in clone hMV3 (Isogai et al., 1996) was amplified
with the sense primer VN1S (50-AGCTGCTAGCACTACATAAAGTC
AAAGTGGGAAAAAG-30), introducing an NheI restriction site at the
50-end, and the antisense primer VN1AS (50-AGCTCTCGAGTCAAT
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Figure 8. Hyaluronidase activity is not detected in solar elastosis. To exclude
the possibility that activated hyaluronidase activity in solar elastosis
reduced the accumulation of hyaluronan, skin pieces from normal and solar
elastosis skin were minced and incubated with hyaluronan. The treated
samples were sieved and the concentrations of HA measured. Incubation with
normal skin and solar elastosis skin did not affect the size or amount of HA.
Incubation with Streptomyces hyaluronidase completely abolished HA (not
shown in the graph).
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GATGATGATGATGATGTCGTTTAAAGCAGTAGGCATCAAATC-30),
introducing a sequence for six histidine residues, a stop codon and a
XhoI restriction site at the 30-end. The NheI–XhoI fragment was
subcloned into pCEP/g2III4, containing the sequence for the BM40/
SPARC signal peptide. The expressed peptide was purified by
chelation chromatography as described previously (Reinhardt et al.,
1996). The polypeptide was further purified by sieve chromatography
through Sephacryl S300 (Amersham Pharmacia Biotech, Tokyo,
Japan) or SDS–PAGE for use in antibody production. The amino-acid
sequence of rVN was analyzed using a Model Procise 494 cLC
protein sequencing system (Applied Biosystems, Foster City, CA). To
test the HA-binding affinity, conditioned medium was incubated with
exogenous HA (Seikagaku Kogyo, Tokyo, Japan) and separated by
density gradient centrifugation. Briefly, following the incubation with
HA, cesium chloride was added to the medium to a final density of
1.36 g/ml and the mixture was centrifuged at 40,000 r.p.m. for
48 hours (Yoneda et al., 1990). Next, the sample was separated into
three fractions (top, middle, and bottom) for analyses.
Antibodies
A rabbit antiserum against rVN was produced by Operon
Biotechnology (Tokyo, Japan). The antiserum was titrated by ELISA
at 1:1000. Monoclonal antibody 2B1 (anti-versican) was characteri-
zed previously (Isogai et al., 1996). mAbs against chondroitinase
ABC-treated stubs, 1B5 and 2B6, were purchased from Seikagaku
Kogyo.
Immunoblotting and transblot assays of skin extracts
Pieces of normal-looking skin were obtained from individuals as
unneeded portions after skin surgery at sun-protected sites. Written
informed consent was obtained from all patients. The study protocol
was approved by the Ethics Committee of the National Center for
Geriatrics and Gerontology, and the study was conducted according
to the Declaration of Helsinki Principles. Following removal of
subcutaneous fatty tissue, skin was weighed, minced into small
pieces (B1 mm), and extracted with 10ml/mg (v/w) of 6 M guanidine
hydrochloride, 50 mM Tris–HCl, pH 7.4, 2 mM CaCl2, and 1 mM
phenylmethylsulfonyl fluoride for 48 hours at 41C. The extract was
concentrated to 6 ml using a Centriplus 30 (Amicon-Millipore,
Billerica, MA) with centrifugation. Next, part of the concentrated
extract was fractionated on a CL-2B Sepharose column (total
volume, 90 ml; fraction number: 68; Amersham Pharmacia Biotech)
in 4 M guanidine hydrochloride and 50 mM Tris-HCl pH 7.5 at a flow
rate of 0.1 ml/minute. The fractions were analyzed by dot blotting
and Western blotting as described previously (Isogai et al., 2002).
Transblot assays using biotin-conjugated HA were performed as
described previously (Zako et al., 2002). Briefly, the blots were
sequentially incubated with biotin-conjugated HA (50 mg/ml in Tris-
buffered saline ) and peroxidase-conjugated streptavidin (1:1,000;
Amersham Pharmacia Biotech), and then developed.
Hyaluronidase treatment of skin
Skin pieces (B200 mg) were incubated with 100 TRU (turbidity
reducing units) of Streptomyces hyaluronidase (Seikagaku Kogyo) in
50 mM acetate buffer, pH 5.0, containing 2 mM PMSF at 371C for
2 hours. Control samples without enzyme treatment were also
prepared. The supernatants were collected by centrifugation at
15,000 r.p.m. at 41C and precipitated for SDS–PAGE analysis. For
some immunohistochemical analyses, skin sections were pretreated
with hyaluronidase before HA detection.
Protease treatment of rVN
Purified rVN (B9mg) and rF23 (B2mg), a recombinant fibrillin-1
peptide (Reinhardt et al., 1996), were treated with 0.12 mg of MMP-
12 (R&D Systems, Minneapolis, MN) in Tris-buffered saline contain-
ing 2 mM CaCl2 at 371C for 6 hours. The digestion was terminated by
the addition of one volume of four-fold-concentrated SDS sample
buffer to three volumes of the sample, followed by heating at 951C
for 5 minutes. The digested samples were analyzed by Western
blotting and HA-binding assays.
Viscosity of versican-bound microfibrils
To study the mechanical properties of hyaluronan–versican–micro-
fibril complexes in solar elastosis, we treated isolated microfibrils
with MMP-12, which is expressed in sun-exposed skin.
Briefly, fetal membranes were extracted with 6 M guanidine
hydrochloride as described previously (Isogai et al., 2003). Subse-
quently, the extract was fractionated on a 120 ml CL-2B molecular
sieve column (Amersham Biosciences, Uppsala, Sweden), equili-
brated with 4 M guanidine hydrochloride/0.1 M Tris–HCl (pH 8.0) at a
flow rate of 0.3 ml/minute, and 3.1-ml fractions were collected
(12 minutes/tube).
After gel chromatography, the samples were brought to a density
of 1.30 g/ml by the addition of CsCl (Yoneda et al., 1990) and a
direct gradient was established by centrifugation at 100,000 g at
101C for 45 hours using a P90AT rotor (Hitachi, Tokyo, Japan). The
gradients were partitioned into 12 fractions. The 6084-positive
fractions were dialyzed against water and incubated with 0.12 mg of
activated recombinant human MMP-12 (R&D Systems) in Tris-
buffered saline containing 2 mM CaCl2 at 371C for 24 hours. Viscosity
was measured using a Cannon-Fenske viscometer at 251C. Viscosity
was measured 40 times. Statistical difference was determined by
two-sided paired-t-test with Po0.0001 considered to represent any
significant difference.
Double-immunofluorescence microscopy
Double-immunofluorescence staining was carried out using for-
malin-fixed paraffin-embedded specimens chosen from specimens
embedded for pathological diagnosis. To simplify the study, we
chose specimens showing advanced solar elastosis and normal sun-
protected skin without inflammation, as evaluated by hematoxylin
–eosin staining. In total, 13 sun-exposed lesion specimens (average
patient age 77.2 years; six from the forehead, five from the cheek,
and two from the nose) and eight sun-protected specimens (average
patient age 73.0 years; three from the abdomen, three from the thigh,
one from the back, and one from the chest) were used. Samples were
stained with 2B1 (1:50), 6084 (1:50), and biotin-conjugated HABR
(Biotin-LP; 1:50; Seikagaku Kogyo). Double immunostaining using
combinations of 2B1 and the above antibodies was also performed.
The secondary antibodies used were rhodamine-conjugated anti-
mouse Ig (1:20: Molecular Probes, Eugene, OR), fluorescein
isothiocyanate-conjugated anti-rabbit Ig (1:25; Vector Laboratories,
Burlingame, CA), and fluorescein isothiocyanate-conjugated strep-
tavidin (1:20; Vector Laboratories). All samples were examined using
an LSM 510 laser scanning confocal microscope (Carl Zeiss,
Oberkochen, Germany).
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Hyaluronidase activity in skin
One sun-exposed cheek skin sample pathologically confirmed as
advanced solar elastosis and one sun-protected abdomen skin
sample were minced, ground and extracted with Cell Lytic-MT
(Sigma, St Louis, MO) at 41C for 10 minutes. Supernatants were
collected after centrifugation. Next, an extract equivalent to 10 mg of
skin was incubated with 1 mg/ml of high molecular weight
hyaluronan (Sigma) in a total volume of 1 ml at 371C for 24 hours.
Streptomyces hyaluronidase (2 TRU) was used as a positive control.
The treated hyaluronan was fractionated on a Superose 6 column
(GE Healthcare, Tokyo, Japan) and monitored by its absorbance
at 232 nm. The HA contents in the fractions were determined
using an HA Assay Kit (IBA method; Seikagaku Corp., Tokyo, Japan)
according to the manufacturer’s instructions.
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